Question 1

Does Citadel Advisors own CTNM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 396,354 shares of CTNM (Contineum Therapeutics), worth $6.5M.

Question 2

How many shares of CTNM does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 396,354 shares of CTNM (Contineum Therapeutics).

Question 3

What is Citadel Advisors' CTNM position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' CTNM position is worth $6.5M.

Question 4

Is Citadel Advisors buying or selling CTNM?

Accepted Answer

In Q2 2026, Citadel Advisors increased its CTNM position by 46,154 shares (+13.2%).

Question 5

When did Citadel Advisors first buy CTNM?

Accepted Answer

Citadel Advisors already held CTNM in its Q2 2024 13F, the earliest on record, and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	396,354	+13.2%	$6.5M	0.0%	$16.39	31
2026-Q1	New	350,200	-	$4.6M	0.0%	$14.10	37
2025-Q3	Exited	0	-100.0%	$0	0.0%	$11.82	0
2025-Q2	New	16,489	-	$65,461	0.0%	$4.11	32
2024-Q3	Exited	0	-100.0%	$0	0.0%	$18.84	0
2024-Q2	New	127,785	-	$2.3M	0.0%	$17.61	36

CTNM6 quarters

CTNM
6 quarters